Abstract 4393: Expression levels of T-cell factor-4 variants in hepato-gastrointestinal cancer cells and tissues
Hironori Koga,Yasuko Imamura,Tomoya Sudo,Hiroyuki Suzuki,Toshimitsu Tanaka,Takahiko Sakaue,Atsutaka Masuda,Hideki Iwamoto,Toru Nakamura,Hirohisa Yano,Takumi Kawaguchi
DOI: https://doi.org/10.1158/1538-7445.am2024-4393
IF: 11.2
2024-03-23
Cancer Research
Abstract:Background: We previously identified 14 variants of T-cell factor (TCF)-4, a key transcriptional factor in the canonical Wnt signaling pathway, from human liver cancer cell lines (Exp Cell Res 2011). The functional analysis of the variants demonstrated that the SxxSS motif played crucial roles in high tumorigenicity, resistance to hypoxia (PLoS ONE 2012), and EMT (Liver Int 2013). These findings suggest that expression levels and patterns of TCF-4 variants tightly regulate diverse phenotypes of cancer cells. Currently, we developed a novel RT-PCR system to quantitatively evaluate TCF-4 variant expressions by using the peptide nucleic acid (PNA)-directed PCR clamping method. Aim: To assess mRNA expression levels of TCF-4 variants in hepato-gastrointestinal cancer cell lines and colon cancer tissues, focusing on TCF-4J and TCF-4K with the presence (K) or absence (J) of the SxxSS motif. Methods: Thirteen cell lines used in this study were as follows: seven liver cancer; one fetus-derived immortalized hepatocyte; one gastric cancer; two pancreatic cancer; and two colon cancer cell lines. The liver cancer cell lines HAK-1A and HAK-1B are clonally sister cell lines. Sets of three forward primers and four reverse primers were used to generate templates for quantitative PCR (qPCR), and three fluorescence (FAM and Cy5)-tagged primers were applied to detect each variant. Thirty-nine resected human cancer and non-cancerous tissue pairs were used in the IRB-certified study (No. 19192). Results: All TCF-4 variants except TCF-4M and TCF-4X were specifically and reproducibly detected and quantified. Cancer cells derived from the colon and stomach highly expressed the TCF-4 variants, showing the highest expression in TCF-4J, while cancer cells from the liver and pancreas expressed relatively lower levels. There was no remarkable difference in the expression profile of TCF-4 variants between HAK-1A and HAK-1B. In colon cancer tissues, TCF-4J was significantly more expressed than TCF-4K. Conclusion: Although the variants had been identified from liver cancer cells, they were universally expressed in cells of other organs. TCF-4J, a variant responsible for aggressive cell phenotype, was prominently found in cancer cells of the digestive tract, where the canonical Wnt signal pathway is known to be constitutively active. A similar variant profile between two liver cancer cell lines with identical clonal origin suggests that the variant pattern in the cells reflects organ-specific traits rather than dynamic phenotypic changes during cancer cell dedifferentiation. Citation Format: Hironori Koga, Yasuko Imamura, Tomoya Sudo, Hiroyuki Suzuki, Toshimitsu Tanaka, Takahiko Sakaue, Atsutaka Masuda, Hideki Iwamoto, Toru Nakamura, Hirohisa Yano, Takumi Kawaguchi. Expression levels of T-cell factor-4 variants in hepato-gastrointestinal cancer cells and tissues [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 4393.
oncology